A detailed history of Keel Point, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Keel Point, LLC holds 6,280 shares of DXCM stock, worth $364,616. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,280
Previous 3,752 67.38%
Holding current value
$364,616
Previous $327,000 29.05%
% of portfolio
0.03%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Dec 16, 2025

BUY
$66.46 - $89.53 $168,010 - $226,331
2,528 Added 67.38%
6,280 $422,000
Q2 2025

Aug 14, 2025

BUY
$59.83 - $87.57 $224,482 - $328,562
3,752 New
3,752 $327,000
Q4 2023

Jan 30, 2024

BUY
$75.49 - $124.16 $127,049 - $208,961
1,683 New
1,683 $208,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Keel Point, LLC Portfolio

Follow Keel Point, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.